UNICONTIN

This brand name is authorized in Nigeria.

Active ingredients

The drug UNICONTIN contains one active pharmaceutical ingredient (API):

1	Theophylline UNII C137DTR5RG - THEOPHYLLINE
	Theophylline is a bronchodilator. In addition it affects the function of a number of cells involved in the inflammatory processes associated with asthma and chronic obstructive airways disease. Theophylline stimulates the myocardium and produces a diminution of venous pressure in congestive heart failure leading to marked increase in cardiac output.
	Read more about Theophylline

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-9425	Tablet	UNICONTIN 600 TABLET TAB 600 mg 1010	UNICONTIN 600 TABLET CONTROLLED RELEASE OF THEOPHYLLINE THEOPHYLLINE ,HYDROXYETHEYL CELLULOSE ,CETOSTEARYL ALCOHOL,MAGNESEUIM STERATE. A4-9425 Drugs Imported Products 1010 POM 2 27/05/2022 PHILLIPS PHARMACEUTICALS (NIGERIA) LTD, APAPA-OSHODI EXPRESSWAY, IYANA-ISOLO LAGOS LAGOS 8035493198 samson.omattah@phillipsnigeria.com MODI MUNDI PHARMA PVT LTD, MODIPURAM 250110 UP INDIA MEERUT MUZAFAAR NAGAR RD , India	26/04/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R03DA04	Theophylline	R Respiratory system → R03 Drugs for obstructive airway diseases → R03D Other systemic drugs for obstructive airway diseases → R03DA Xanthines
Discover more medicines within R03DA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-9425